-
1
-
-
25744436267
-
Malignant pleural mesothelioma (MPM) in Slovenia, 1980-1997
-
abstract
-
Kovac V, Debevec M, Plaper-Vernik M, et al. Malignant pleural mesothelioma (MPM) in Slovenia, 1980-1997. Lung Cancer 2001;32:S57 (abstract).
-
(2001)
Lung Cancer
, vol.32
-
-
Kovac, V.1
Debevec, M.2
Plaper-Vernik, M.3
-
2
-
-
0041629528
-
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
-
DOI 10.1200/JCO.2003.11.136
-
Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-2644. (Pubitemid 46606305)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.14
, pp. 2636-2644
-
-
Vogelzang, N.J.1
Rusthoven, J.J.2
Symanowski, J.3
Denham, C.4
Kaukel, E.5
Ruffie, P.6
Gatzemeier, U.7
Boyer, M.8
Emri, S.9
Manegold, C.10
Niyikiza, C.11
Paoletti, P.12
-
3
-
-
67349198885
-
Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: A review of practice in British Columbia
-
Lee CW, Murray N, Anderson H, Rao SC, Bishop W. Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia. Lung Cancer 2009;64:308-313.
-
(2009)
Lung Cancer
, vol.64
, pp. 308-313
-
-
Lee, C.W.1
Murray, N.2
Anderson, H.3
Rao, S.C.4
Bishop, W.5
-
4
-
-
0036023405
-
Gemcitabine (2',2'-difluoro-2'-deoxycytidine), an antimetabolite that poisons topoisomerase I
-
Pourquier P, Gioffre C, Kohlhagen G, et al. Gemcitabine (2',2'-difluoro-2'-deoxycytidine), an antimetabolite that poisons topoisomerase I. Clin Cancer Res 2002;8:2499-2504. (Pubitemid 34856331)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.8
, pp. 2499-2504
-
-
Pourquier, P.1
Gioffre, C.2
Kohlhagen, G.3
Urasaki, Y.4
Goldwasser, F.5
Hertel, L.W.6
Yu, S.7
Pon, R.T.8
Gmeiner, W.H.9
Pommier, Y.10
-
5
-
-
0141425710
-
Structural basis for topoisomerase I inhibition by nucleoside analogs
-
DOI 10.1081/NCN-120022604
-
Gmeiner WH, Yu S, Pon RT, Pourquier P, Pommier Y. Structural basis for topoisomerase I inhibition by nucleoside analogs. Nucleosides Nucleotides Nucleic Acids 2003;22:653-658. (Pubitemid 37139225)
-
(2003)
Nucleosides, Nucleotides and Nucleic Acids
, vol.22
, Issue.5-8
, pp. 653-658
-
-
Gmeiner, W.H.1
Yu, S.2
Pon, R.T.3
Pourquier, P.4
Pommier, Y.5
-
6
-
-
79954575723
-
Novel role of base excision repair in mediating cisplatin cytotoxicity
-
Kothandapani A, Dangeti VS, Brown AR, et al. Novel role of base excision repair in mediating cisplatin cytotoxicity. J Biol Chem 2011;286:14564-14574.
-
(2011)
J Biol Chem
, vol.286
, pp. 14564-14574
-
-
Kothandapani, A.1
Dangeti, V.S.2
Brown, A.R.3
-
7
-
-
0029875635
-
Synergistic interaction between cisplatin and gemcitabine in vitro
-
Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Peters GJ. Synergistic interaction between cisplatin and gemcitabine in vitro. Clin Cancer Res 1996;2:521-530. (Pubitemid 26099172)
-
(1996)
Clinical Cancer Research
, vol.2
, Issue.3
, pp. 521-530
-
-
Bergman, A.M.1
Ruiz Van Haperen, V.W.T.2
Veerman, G.3
Kuiper, C.M.4
Peters, G.J.5
-
8
-
-
79953800571
-
Vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: Evidence for sequence-dependent effects
-
Zanellato I, Boidi CD, Lingua G, et al. In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects. Cancer Chemother Pharmacol 2011;67:265-273.
-
(2011)
Cancer Chemother Pharmacol
, vol.67
, pp. 265-273
-
-
Zanellato, I.1
Boidi, C.D.2
Lingua, G.3
-
9
-
-
0033955346
-
XRCC1 keeps DNA from getting stranded
-
DOI 10.1016/S0921-8777(99)00058-0, PII S0921877799000580
-
Thompson LH, West MG. XRCC1 keeps DNA from getting stranded. Mutat Res 2000;459:1-18. (Pubitemid 30085463)
-
(2000)
Mutation Research - DNA Repair
, vol.459
, Issue.1
, pp. 1-18
-
-
Thompson, L.H.1
West, M.G.2
-
10
-
-
33645298447
-
Polymorphisms in DNA repair genes modulate survival in cisplatingemcitabine-treated non-small-cell lung cancer patients
-
Spanish Lung Cancer Group
-
de las Peñas R, Sanchez-Ronco M, Alberola V, et al.; Spanish Lung Cancer Group. Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Ann Oncol 2006;17:668-675.
-
(2006)
Ann Oncol
, vol.17
, pp. 668-675
-
-
De Las Peñas, R.1
Sanchez-Ronco, M.2
Alberola, V.3
-
11
-
-
80655148792
-
Genetic polymorphisms of GSTP1 and XRCC1: Prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients
-
Zhou F, Yu Z, Jiang T, Lv H, Yao R, Liang J. Genetic polymorphisms of GSTP1 and XRCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients. Swiss Med Wkly 2011;141:w13275.
-
(2011)
Swiss Med Wkly
, vol.141
-
-
Zhou, F.1
Yu, Z.2
Jiang, T.3
Lv, H.4
Yao, R.5
Liang, J.6
-
12
-
-
83655164249
-
The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma
-
Erculj N, Kovac V, Hmeljak J, Franko A, Dodic-Fikfak M, Dolžan V. The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma. Pharmacogenet Genomics 2012;22:58-68.
-
(2012)
Pharmacogenet Genomics
, vol.22
, pp. 58-68
-
-
Erculj, N.1
Kovac, V.2
Hmeljak, J.3
Franko, A.4
Dodic-Fikfak, M.5
Dolžan, V.6
-
13
-
-
84855210829
-
A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma
-
Kovac V, Zwitter M, Rajer M, et al. A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma. Anticancer Drugs 2012;23:230-238.
-
(2012)
Anticancer Drugs
, vol.23
, pp. 230-238
-
-
Kovac, V.1
Zwitter, M.2
Rajer, M.3
-
14
-
-
84859514200
-
The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma
-
Erculj N, Kovac V, Hmeljak J, Dolžan V. The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma. Ann Oncol 2012;23:961-967.
-
(2012)
Ann Oncol
, vol.23
, pp. 961-967
-
-
Erculj, N.1
Kovac, V.2
Hmeljak, J.3
Dolžan, V.4
-
15
-
-
0035173378
-
DbSNP: The NCBI database of genetic variation
-
Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001;29:308-311. (Pubitemid 32054478)
-
(2001)
Nucleic Acids Research
, vol.29
, Issue.1
, pp. 308-311
-
-
Sherry, S.T.1
Ward, M.-H.2
Kholodov, M.3
Baker, J.4
Phan, L.5
Smigielski, E.M.6
Sirotkin, K.7
-
16
-
-
79959503826
-
The international HapMap project
-
Consortium IH. The international HapMap project. Nature 2003;426:789-796.
-
(2003)
Nature
, vol.426
, pp. 789-796
-
-
Consortium, I.H.1
-
17
-
-
67849101182
-
SNPinfo: Integrating GWAS and candidate gene information into functional SNP selection for genetic association studies
-
Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 2009;37(Web Server issue):W600-W605.
-
(2009)
Nucleic Acids Res
, vol.37
, Issue.WEB SERVER ISSUE
-
-
Xu, Z.1
Taylor, J.A.2
-
18
-
-
33747832183
-
FASTSNP: An always up-to-date and extendable service for SNP function analysis and prioritization
-
Yuan HY, Chiou JJ, Tseng WH, et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006;34(Web Server issue):W635-W641.
-
(2006)
Nucleic Acids Res
, vol.34
, Issue.WEB SERVER ISSUE
-
-
Yuan, H.Y.1
Chiou, J.J.2
Tseng, W.H.3
-
19
-
-
78650455185
-
No implication of Simian virus 40 in pathogenesis of malignant pleural mesothelioma in Slovenia
-
Hmeljak J, Kern I, Cor A. No implication of Simian virus 40 in pathogenesis of malignant pleural mesothelioma in Slovenia. Tumori 2010;96:667-673.
-
(2010)
Tumori
, vol.96
, pp. 667-673
-
-
Hmeljak, J.1
Kern, I.2
Cor, A.3
-
20
-
-
77949694767
-
Genetic polymorphisms in base excision repair in healthy Slovenian population and their influence on DNA damage
-
Erculj N, Zadel M, Dolzan V. Genetic polymorphisms in base excision repair in healthy Slovenian population and their influence on DNA damage. Acta Chimica Slovenica 2010;57:182-188.
-
(2010)
Acta Chimica Slovenica
, vol.57
, pp. 182-188
-
-
Erculj, N.1
Zadel, M.2
Dolzan, V.3
-
21
-
-
84858246336
-
Genetic polymorphisms in homologous recombination repair genes in healthy Slovenian population and their influence on DNA damage
-
Goricar K, Erculj N, Zadel M, et al. Genetic polymorphisms in homologous recombination repair genes in healthy Slovenian population and their influence on DNA damage. Radiol Oncol 2012;46:46-53.
-
(2012)
Radiol Oncol
, vol.46
, pp. 46-53
-
-
Goricar, K.1
Erculj, N.2
Zadel, M.3
-
22
-
-
34249662218
-
A new JAVA interface implementation of THESIAS: Testing haplotype effects in association studies
-
DOI 10.1093/bioinformatics/btm058
-
Tregouet DA, Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007;23:1038-1039. (Pubitemid 47050595)
-
(2007)
Bioinformatics
, vol.23
, Issue.8
, pp. 1038-1039
-
-
Tregouet, D.A.1
Garelle, V.2
-
23
-
-
68249162551
-
The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma
-
Cheng XD, Lu WG, Ye F, Wan XY, Xie X. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma. J Exp Clin Cancer Res 2009;28:91.
-
(2009)
J Exp Clin Cancer Res
, vol.28
, pp. 91
-
-
Cheng, X.D.1
Lu, W.G.2
Ye, F.3
Wan, X.Y.4
Xie, X.5
-
24
-
-
65349117547
-
DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer
-
Kalikaki A, Kanaki M, Vassalou H, et al. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer 2009;10:118-123.
-
(2009)
Clin Lung Cancer
, vol.10
, pp. 118-123
-
-
Kalikaki, A.1
Kanaki, M.2
Vassalou, H.3
-
25
-
-
67649971566
-
Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: A study of the arbeitsgemeinschaft internistische onkologie
-
Goekkurt E, Al-Batran SE, Hartmann JT, et al. Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie. J Clin Oncol 2009;27:2863-2873.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2863-2873
-
-
Goekkurt, E.1
Al-Batran, S.E.2
Hartmann, J.T.3
-
26
-
-
34848912861
-
Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population
-
DOI 10.1038/sj.ejhg.5201884, PII 5201884
-
Liu B, Wei J, Zou Z, et al. Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population. Eur J Hum Genet 2007;15:1049-1053. (Pubitemid 47491460)
-
(2007)
European Journal of Human Genetics
, vol.15
, Issue.10
, pp. 1049-1053
-
-
Liu, B.1
Wei, J.2
Zou, Z.3
Qian, X.4
Nakamura, T.5
Zhang, W.6
Ding, Y.7
Feng, J.8
Yu, L.9
-
27
-
-
4344567395
-
XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy
-
DOI 10.1200/JCO.2004.08.067
-
Gurubhagavatula S, Liu G, Park S, et al. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 2004;22:2594-2601. (Pubitemid 41103746)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.13
, pp. 2594-2601
-
-
Gurubhagavatula, S.1
Liu, G.2
Park, S.3
Zhou, W.4
Su, L.5
Wain, J.C.6
Lynch, T.J.7
Neuberg, D.S.8
Christiani, D.C.9
-
28
-
-
84860216677
-
Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: A prospective clinical study
-
Joerger M, Burgers SA, Baas P, et al. Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study. Cancer 2012;118:2466-2475.
-
(2012)
Cancer
, vol.118
, pp. 2466-2475
-
-
Joerger, M.1
Burgers, S.A.2
Baas, P.3
-
29
-
-
84872821769
-
DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy
-
Published Ahead of Print, July 31
-
Li D, Zhou Q, Liu Y, et al. DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy. Med Oncol Published Ahead of Print, July 31, 2011.
-
Med Oncol
, pp. 2011
-
-
Li, D.1
Zhou, Q.2
Liu, Y.3
-
30
-
-
34249812370
-
Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer
-
DOI 10.1158/1078-0432.CCR-06-2543
-
Giachino DF, Ghio P, Regazzoni S, et al. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. Clin Cancer Res 2007;13:2876-2881. (Pubitemid 46849561)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.10
, pp. 2876-2881
-
-
Giachino, D.F.1
Ghio, P.2
Regazzoni, S.3
Mandrile, G.4
Novello, S.5
Selvaggi, G.6
Gregori, D.7
DeMarchi, M.8
Scagliotti, G.V.9
-
31
-
-
0346243565
-
Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays
-
Au WW, Salama SA, Sierra-Torres CH. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 2003;111:1843-1850. (Pubitemid 37526965)
-
(2003)
Environmental Health Perspectives
, vol.111
, Issue.15
, pp. 1843-1850
-
-
Au, W.W.1
Salama, S.A.2
Sierra-Torres, C.H.3
-
32
-
-
0033152748
-
1-DNA adducts and glycophorin A variant frequency
-
Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-2561. (Pubitemid 29269097)
-
(1999)
Cancer Research
, vol.59
, Issue.11
, pp. 2557-2561
-
-
Lunn, R.M.1
Langlois, R.G.2
Hsieh, L.L.3
Thompson, C.L.4
Bell, D.A.5
-
33
-
-
0034098801
-
Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells
-
Duell EJ, Wiencke JK, Cheng TJ, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000;21:965-971. (Pubitemid 30265141)
-
(2000)
Carcinogenesis
, vol.21
, Issue.5
, pp. 965-971
-
-
Duell, E.J.1
Wiencke, J.K.2
Cheng, T.-J.3
Varkonyi, A.4
Zuo, Z.F.5
Ashok, T.D.S.6
Mark, E.J.7
Wain, J.C.8
Christiani, D.C.9
Kelsey, K.T.10
-
34
-
-
20244363386
-
High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy
-
DOI 10.1158/1078-0432.CCR-04-2176
-
Chang JY, Komaki R, Sasaki R, et al. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy. Clin Cancer Res 2005;11:2894-2898. (Pubitemid 40525190)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.8
, pp. 2894-2898
-
-
Chang, J.Y.1
Komaki, R.2
Sasaki, R.3
Liao, Z.4
Stevens, C.W.5
Lu, C.6
Fossella, F.V.7
Allen, P.K.8
Cox, J.D.9
Spitz, M.R.10
Wu, X.11
-
36
-
-
57649101361
-
Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer
-
Lee JG, Cho BC, Bae MK, Claire VM. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer. Lung Cancer 2009;63:106-110.
-
(2009)
Lung Cancer
, vol.63
, pp. 106-110
-
-
Lee, J.G.1
Cho, B.C.2
Bae, M.K.3
Claire, V.M.4
-
37
-
-
27644497125
-
Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients
-
DOI 10.1158/1078-0432.CCR-04-2657
-
Chang-Claude J, Popanda O, Tan XL, et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 2005;11:4802-4809. (Pubitemid 41557201)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.13
, pp. 4802-4809
-
-
Chang-Claude, J.1
Popanda, O.2
Tan, X.-L.3
Kropp, S.4
Helmbold, I.5
Von Fournier, D.6
Haase, W.7
Sautter-Bihl, M.L.8
Wenz, F.9
Schmezer, P.10
Ambrosone, C.B.11
-
38
-
-
79961128370
-
Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients
-
Mangoni M, Bisanzi S, Carozzi F, et al. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys 2011;81:52-58.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. 52-58
-
-
Mangoni, M.1
Bisanzi, S.2
Carozzi, F.3
-
39
-
-
75549089797
-
Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients
-
Khrunin AV, Moisseev A, Gorbunova V, Limborska S. Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients. Pharmacogenomics J 2010;10:54-61.
-
(2010)
Pharmacogenomics J
, vol.10
, pp. 54-61
-
-
Khrunin, A.V.1
Moisseev, A.2
Gorbunova, V.3
Limborska, S.4
-
40
-
-
77954355121
-
Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers
-
Park SL, Bastani D, Goldstein BY, et al. Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers. Carcinogenesis 2010;31:1264-1271.
-
(2010)
Carcinogenesis
, vol.31
, pp. 1264-1271
-
-
Park, S.L.1
Bastani, D.2
Goldstein, B.Y.3
-
41
-
-
77954680606
-
Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy
-
Nogueira A, Catarino R, Coelho A, Araújo A, Gomes M, Medeiros R. Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy. Cancer Chemother Pharmacol 2010;66:501-506.
-
(2010)
Cancer Chemother Pharmacol
, vol.66
, pp. 501-506
-
-
Nogueira, A.1
Catarino, R.2
Coelho, A.3
Araújo, A.4
Gomes, M.5
Medeiros, R.6
-
42
-
-
34247118310
-
Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes
-
DOI 10.1016/j.canlet.2006.11.011, PII S0304383506006197
-
Nagle CM, Chenevix-Trench G, Webb PM, Spurdle AB. Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes. Cancer Lett 2007;251:96-104. (Pubitemid 46589770)
-
(2007)
Cancer Letters
, vol.251
, Issue.1
, pp. 96-104
-
-
Nagle, C.M.1
Chenevix-Trench, G.2
Webb, P.M.3
Spurdle, A.B.4
-
43
-
-
0344676392
-
Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes
-
DOI 10.1016/j.radonc.2003.09.010
-
Andreassen CN, Alsner J, Overgaard M, Overgaard J. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 2003;69:127-135. (Pubitemid 37485871)
-
(2003)
Radiotherapy and Oncology
, vol.69
, Issue.2
, pp. 127-135
-
-
Andreassen, C.N.1
Alsner, J.2
Overgaard, M.3
Overgaard, J.4
-
44
-
-
34247374739
-
Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials
-
DOI 10.1182/blood-2006-05-022111
-
Kuptsova N, Kopecky KJ, Godwin J, et al. Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood 2007;109:3936-3944. (Pubitemid 46641746)
-
(2007)
Blood
, vol.109
, Issue.9
, pp. 3936-3944
-
-
Kuptsova, N.1
Kopecky, K.J.2
Godwin, J.3
Anderson, J.4
Hoque, A.5
Willman, C.L.6
Slovak, M.L.7
Ambrosone, C.B.8
-
45
-
-
33646411483
-
Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer
-
Damaraju S, Murray D, Dufour J, et al. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res 2006;12:2545-2554.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 2545-2554
-
-
Damaraju, S.1
Murray, D.2
Dufour, J.3
-
46
-
-
78649327372
-
A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma
-
Tanrikulu AC, Abakay A, Kaplan MA, et al. A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma. Respiration 2010;80:480-487.
-
(2010)
Respiration
, vol.80
, pp. 480-487
-
-
Tanrikulu, A.C.1
Abakay, A.2
Kaplan, M.A.3
-
47
-
-
78650794570
-
Survival and prognostic factors in malignant pleural mesothelioma: A retrospective study of 314 patients in the west part of Japan
-
Nojiri S, Gemba K, Aoe K, et al. Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan. Jpn J Clin Oncol 2011;41:32-39.
-
(2011)
Jpn J Clin Oncol
, vol.41
, pp. 32-39
-
-
Nojiri, S.1
Gemba, K.2
Aoe, K.3
-
48
-
-
79952186170
-
Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma
-
Ceresoli GL, Zucali PA, De Vincenzo F, et al. Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma. Lung Cancer 2011;72:73-77.
-
(2011)
Lung Cancer
, vol.72
, pp. 73-77
-
-
Ceresoli, G.L.1
Zucali, P.A.2
De Vincenzo, F.3
-
49
-
-
34447303456
-
Pharmacokinetics of gemcitabine in Japanese cancer patients: The impact of a cytidine deaminase polymorphism
-
DOI 10.1200/JCO.2006.06.7405
-
Sugiyama E, Kaniwa N, Kim SR, et al. Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism. J Clin Oncol 2007;25:32-42. (Pubitemid 350003048)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.1
, pp. 32-42
-
-
Sugiyama, E.1
Kaniwa, N.2
Kim, S.-R.3
Kikura-Hanajiri, R.4
Hasegawa, R.5
Maekawa, K.6
Saito, Y.7
Ozawa, S.8
Sawada, J.-I.9
Kamatani, N.10
Furuse, J.11
Ishii, H.12
Yoshida, T.13
Ueno, H.14
Okusaka, T.15
Saijo, N.16
-
50
-
-
67651245077
-
Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients
-
Jakobsen JN Herrstedt J. Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients. Crit Rev Oncol Hematol 2009;71:214-221.
-
(2009)
Crit Rev Oncol Hematol
, vol.71
, pp. 214-221
-
-
Jakobsen, J.N.1
Herrstedt, J.2
-
51
-
-
34047183132
-
Precision instrumentation for rolling element bearing characterization
-
Marsh ER, Vigliano VC, Weiss JR, Moerlein AW, Vallance RR. Precision instrumentation for rolling element bearing characterization. Rev Sci Instrum 2007;78:035113.
-
(2007)
Rev Sci Instrum
, vol.78
, pp. 035113
-
-
Marsh, E.R.1
Vigliano, V.C.2
Weiss, J.R.3
Moerlein, A.W.4
Vallance, R.R.5
-
52
-
-
0001851975
-
Slovenian caucasian normal
-
PI Terasaki, DW Gjerston (Eds.). Lenexa: American Society for Histocompatibility and Immunogenetics
-
Vidan-Jeras B, Jurca B, Dolzan V, et al. Slovenian caucasian normal. In PI Terasaki, DW Gjerston (Eds.), HLA 1998. Lenexa: American Society for Histocompatibility and Immunogenetics, 1998. Pp. 180-181.
-
(1998)
HLA 1998
, pp. 180-181
-
-
Vidan-Jeras, B.1
Jurca, B.2
Dolzan, V.3
|